BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/19/2026 7:13:10 AM | Browse: 0 | Download: 0
 |
Received |
|
2025-11-12 02:24 |
|
Peer-Review Started |
|
2025-11-12 02:24 |
|
First Decision by Editorial Office Director |
|
2025-12-25 08:17 |
|
Return for Revision |
|
2025-12-25 08:17 |
|
Revised |
|
2026-01-16 13:47 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-04-07 02:45 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-04-07 10:37 |
|
Articles in Press |
|
2026-04-07 10:37 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-05-12 00:48 |
|
Publish the Manuscript Online |
|
2026-05-19 07:13 |
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Editorial |
| Article Title |
Bioresorbable scaffolds in acute coronary syndrome: A promising alternative to drug-eluting stents or a step too soon?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Zainab A Dakhil |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Zainab A Dakhil, Assistant Professor, Department of Cardiology, Ibn Al-Bitar Cardiac Center/University of Baghdad, Al-Naseer Street, Baghdad 10003, Iraq. stethoscope.med@gmail.com |
| Key Words |
Bioresorbable vascular scaffold; NeoVasc; Magnesium-based scaffold; Thrombosis; Pre-dilation; Sizing; Post-dilation |
| Core Tip |
Bioresorbable scaffolds aim to provide temporary coronary support with drug delivery while ultimately restoring a device-free artery. In acute coronary syndrome, evidence remains cautious: First-generation polymeric scaffolds showed increased thrombosis during the resorption phase, and newer platforms require rigorous implantation discipline. The study by Li et al discussed here used the NeoVas sirolimus-eluting poly-L-lactic acid scaffold and reported comparable mid-term outcomes to drug-eluting stents, with reduced inflammatory biomarkers at 1 month. These signals are hypothesis-generating; definitive adoption requires randomized trials with imaging and long-term follow-up. |
| Publish Date |
2026-05-19 07:13 |
| Citation |
Dakhil ZA. Bioresorbable scaffolds in acute coronary syndrome: A promising alternative to drug-eluting stents or a step too soon? World J Cardiol 2026; 18(5): 116478 |
| URL |
https://www.wjgnet.com/1949-8462/full/v18/i5/116478.htm |
| DOI |
https://dx.doi.org/10.4330/wjc.v18.i5.116478 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
